A systematic review and meta-analysis of international COVID-19 literature, led by UNSW Sydney, has confirmed that while children under five years old were likely to recover...
Reports of possible allergic reactions to the COVID-19 vaccines produced by Pfizer-BioNTech and Moderna, both recently approved for emergency use by the U.S. Food and Drug...
A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to...
COVID-19 antibodies preferentially target a different part of the virus in mild cases of COVID-19 than they do in severe cases, and wane significantly within several...
People with severe COVID-19 and a secondary blood infection were significantly sicker upon hospital admission, had longer hospital stays and poorer outcomes, according to a Rutgers...
National Institutes of Health researchers have isolated a set of promising, tiny antibodies, or “nanobodies,” against SARS-CoV-2 that were produced by a llama named Cormac. Preliminary...
High rates of COVID-19 in the county where a hospital is located appears to reduce survival rates among hospitalized patients with the virus, according to a...
Simply wearing a mask may not be enough to prevent the spread of COVID-19 without social distancing. In Physics of Fluids, by AIP Publishing, researchers tested how...
A mathematical model that can help project the contagiousness and spread of infectious diseases like the seasonal flu may not be the best way to predict...
By taking a lesson from prostate cancer, researchers now have a promising lead on a treatment for COVID-19. Two proteins, ACE2 and TMPRSS2, help the coronavirus...
